Quantcast
Last updated on April 19, 2014 at 7:50 EDT

Latest oral contraceptives Stories

2014-02-26 12:25:51

Research shows patented pine bark extract plays a key role in reducing inflammation associated with endometriosis and menstruation, which affects more than 5 million U.S. women HOBOKEN, N.J., Feb. 26, 2014 /PRNewswire/ -- An observational study published in the December 2013 issue of the International Journal of Women's Health found that the natural supplement Pycnogenol(®) (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, significantly minimizes...

Oral Contraceptive Linked To Glaucoma
2013-11-18 15:24:18

Rebekah Eliason for redOrbit.com – Your Universe Online Millions of women choose oral contraceptives as an easy method of birth control, but new research has discovered their use is linked to serious eye disease. Using oral contraceptives for three years or longer doubles the risk of glaucoma, which is a leading cause of blindness that affects approximately 60 million people throughout the world. Researchers are informing gynecologists and ophthalmologists of the possible part oral...

2013-11-18 08:29:18

Research shows birth control use over three years could be a risk factor for glaucoma NEW ORLEANS, Nov. 18, 2013 /PRNewswire-USNewswire/ -- Research presented today, at the 117(th) Annual Meeting of the American Academy of Ophthalmology in New Orleans, has found that women who have taken oral contraceptives for three or more years are twice as likely to suffer from glaucoma, one of the leading causes of blindness which affects nearly 60 million worldwide.[I] The researchers caution...

2013-05-06 23:19:37

New research by New York's Center for Human Reproduction demonstrates that oral contraceptives - routinely used by fertility centers in IVF - may reduce egg yields. New York, NY (PRWEB) May 06, 2013 Some oral contraceptives with stronger androgenic characteristics may reduce pregnancy chances with IVF, reports a new study conducted by the Center for Human Reproduction (CHR), a research-driven fertility center in New York City. The study, just published in Reproductive Biology and...

2012-12-28 12:22:29

PITTSBURGH, Dec. 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its partner Famy Care Ltd. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg. This product is the generic version of Teva Branded Pharmaceutical Products' Nordette® 28 Tablets, which are indicated for the prevention of pregnancy in women who elect to use this...

2012-12-03 20:55:35

Women with polycystic ovary syndrome (PCOS) who are taking combined oral contraceptives have a 2-fold risk of blood clots compared with women without the disorder who take contraceptives, states a study published in CMAJ (Canadian Medical Association Journal). PCOS affects between 6% and 10% of women of reproductive age with some estimates as high as 15%, making it the most common endocrine disorder in this age group. Risk factors for heart disease such as hypertension, diabetes, obesity...

2012-11-08 16:27:16

PITTSBURGH, Nov. 8, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Norgestimate/Ethinyl Estradiol Tablets 0.180 mg/0.025 mg, 0.215 mg/0.025 mg and 0.250 mg/0.025 mg. Norgestimate/Ethinyl Estradiol Tablets are the generic version of Janssen Pharmaceuticals Inc.'s Ortho Tri-Cyclen Lo(®) Tablets, which are indicated for...

2012-09-18 10:24:38

NEW YORK, Sept. 18, 2012 /PRNewswire/ -- According to the Guttmacher Institute, over ten million women in the US use oral contraceptives. Although birth control pills are an effective way to prevent pregnancy, keep acne at bay, and treat menstrual pain or irregularity, there may be some health concerns that are undisclosed to patients. A recent study suggests that oral contraceptive use can lead to increased pain during intercourse, with decreased libido and spontaneous arousability as well...

2012-05-22 02:30:15

New research being presented at Digestive Disease Week® (DDW) offers key insights into the prevention and treatment of bowel diseases, which affect millions of people worldwide. Several studies show that factors, including common dietary additives, hormone replacement therapy, oral contraceptives and even high-altitude travel may cause or exacerbate these diseases. Other research examines the effect of cutting-edge therapies on ulcerative colitis and Crohn's disease, collectively known as...

2012-03-17 23:02:07

In March 2012, Bayer Healthcare reported that it had reached agreements, without admission of liability, to settle the claims of approximately 70 plaintiffs on Yasmin/Yaz lawsuits in the U.S. at terms and conditions which Bayer views to be reasonable. Yasmin, which was approved by the FDA in 2001, and Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. They are also used to treat premenstrual...